Phase I Dose Escalation and Pharmacokinetics Study of the Radiosensitizer, Gadolinium Texaphyrin (Gd-Tex, NSC 695238) With Concurrent Radiotherapy in Advanced Biliary Tree and Pancreatic Cancers
Phase of Trial: Phase I
Latest Information Update: 26 Jan 2016
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Biliary cancer; Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Nov 2007 New trial centres added.
- 07 Sep 2006 Status change
- 19 Sep 2005 New trial record.